Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Professor, students create nanomedicine treatments

Texas A&M Chemistry professor Karen Wooley
Texas A&M Chemistry professor Karen Wooley

Abstract:
Texas A&M is one of the world's leading research facilities. It invests more than $582 million annually toward research, which ranks the University third in the nation. A&M is also one of five institutions with research funded towards nanotechnology-based therapies and diagnostics tools for the treatment of heart and lung disease.

By Joyce Go

Professor, students create nanomedicine treatments

College Station, TX | Posted on November 4th, 2010

Chemistry professor Karen Wooley is the co-principal investigator for nanoparticle-focused research at A&M.

"My laboratory has been developing polymer nanoparticles for the past 15 years, the past year of which has been here at A&M. A part of our work focuses on the fundamental aspects of developing synthetic methodologies by which nanoparticles can be prepared together with rigorous study of their structures and properties," Wooley said. "Another part emphasizes practical applications for nanotechnology, one of which is in medicine."

Wooley holds the position as W.T. Doherty-Welch Chair in Chemistry at A&M, and is regarded as one of the top chemists in material and polymer chemistry worldwide.

"My interest in nanotechnology stems from the applied interest in producing materials that can benefit society and also the scientific challenges involved in the synthesis of the materials with exquisite control over their compositions, structures and properties," Wooley said.

The medical aspect of nanotechnology research, known as nanomedicine, works to increase non-invasive diagnostic methods and treatment. Researchers at A&M are working towards treatment for lung diseases and injuries.

"Our group (*) has been involved in cutting-edge macromolecular science following Professor Wooley's discovery of shell-crosslinked knedels in the '90s," said Yun Lin, a chemistry graduate student working under Wooley. "The potential applications of this concept are immense: SCKs of fascinating morphologies have been shown to serve as the next-generation nanomedicine by delivering drugs to specific sites in the body."

Wooley's team consists of graduate students and post-doctoral associates who use knowledge of polymer chemistry to improve the efficiency of medical technology.

"Professor Wooley and her group are outspoken - constantly involved in dissemination activities throughout the world and the nation to speak to the peers and the general public about our scientific findings and the safety of the technology," said Nam Lee, a chemistry graduate student also working in Wooley's laboratory.

(*) wooleyweb.chemistry.wustl.edu

####

For more information, please click here

Contacts:
Karen Wooley
Phone: (979) 845-4077
Fax: (979) 862-1137

Copyright © Texas A&M

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chemistry

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Academic/Education

Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

National Space Society Helps Fund Expanding Frontier’s Brownsville Summer Entrepreneur Academy: National Space Society and Club for the Future to Support Youth Development Program in South Texas June 24th, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project